Cargando…

Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity

Recent studies provide some evidence for the contribution of antibody-mediated autoimmune mechanisms to the nature of fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Much attention was paid to the autoantibodies (AAb) targeting G protein-coupled receptors as natura...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryabkova, Varvara A., Gavrilova, Natalia Y., Poletaeva, Alina A., Pukhalenko, Alexander I., Koshkina, Irina A., Churilov, Leonid P., Shoenfeld, Yehuda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952981/
https://www.ncbi.nlm.nih.gov/pubmed/36830795
http://dx.doi.org/10.3390/biomedicines11020257
_version_ 1784893764426268672
author Ryabkova, Varvara A.
Gavrilova, Natalia Y.
Poletaeva, Alina A.
Pukhalenko, Alexander I.
Koshkina, Irina A.
Churilov, Leonid P.
Shoenfeld, Yehuda
author_facet Ryabkova, Varvara A.
Gavrilova, Natalia Y.
Poletaeva, Alina A.
Pukhalenko, Alexander I.
Koshkina, Irina A.
Churilov, Leonid P.
Shoenfeld, Yehuda
author_sort Ryabkova, Varvara A.
collection PubMed
description Recent studies provide some evidence for the contribution of antibody-mediated autoimmune mechanisms to the nature of fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Much attention was paid to the autoantibodies (AAb) targeting G protein-coupled receptors as natural components of the immune system. However, the natural AAb network is much more extensive, and has not been previously investigated in these disorders. The enzyme immunoassays ELI-Viscero-Test and ELI-Neuro-Test were used to determine changes in serum content of 33 natural AAb to neural, organ-specific and non-tissue-specific autoantigens (a) in 11 ME/CFS patients with comorbid FM; (b) in 11 ME/CFS patients without FM; (c) in 11 healthy controls. Individual AAb profiles and their correlation with some clinical symptoms were analyzed. Both patients with ME/CFS(−)FM and ME/CFS(+)FM were characterized by more frequent and pronounced deviations in the immunoreactivity to GABA-receptors than healthy controls. Although the level of other natural AAb did not differ between study groups, AAb correlation signatures were altered in patients compared to healthy controls. Both in patients and healthy controls the level of natural AAb to various neural and tissue-specific antigens correlated with the severity of fatigue, bodily pain, depression, anxiety, physical and mental health-related quality of life. Notably, widely different correlation patterns were observed between study groups. Findings from this pilot study provide some evidence that the homeostasis of autoimmune relationships, which are possibly a physiological part of our immune system, may be altered in FM and ME/CFS. The correlation of disease-induced perturbations in individual AAb profiles with some clinical symptoms may arise from the immune system’s ability to reflect qualitative and quantitative changes in antigenic composition of the body.
format Online
Article
Text
id pubmed-9952981
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-99529812023-02-25 Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity Ryabkova, Varvara A. Gavrilova, Natalia Y. Poletaeva, Alina A. Pukhalenko, Alexander I. Koshkina, Irina A. Churilov, Leonid P. Shoenfeld, Yehuda Biomedicines Article Recent studies provide some evidence for the contribution of antibody-mediated autoimmune mechanisms to the nature of fibromyalgia (FM) and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Much attention was paid to the autoantibodies (AAb) targeting G protein-coupled receptors as natural components of the immune system. However, the natural AAb network is much more extensive, and has not been previously investigated in these disorders. The enzyme immunoassays ELI-Viscero-Test and ELI-Neuro-Test were used to determine changes in serum content of 33 natural AAb to neural, organ-specific and non-tissue-specific autoantigens (a) in 11 ME/CFS patients with comorbid FM; (b) in 11 ME/CFS patients without FM; (c) in 11 healthy controls. Individual AAb profiles and their correlation with some clinical symptoms were analyzed. Both patients with ME/CFS(−)FM and ME/CFS(+)FM were characterized by more frequent and pronounced deviations in the immunoreactivity to GABA-receptors than healthy controls. Although the level of other natural AAb did not differ between study groups, AAb correlation signatures were altered in patients compared to healthy controls. Both in patients and healthy controls the level of natural AAb to various neural and tissue-specific antigens correlated with the severity of fatigue, bodily pain, depression, anxiety, physical and mental health-related quality of life. Notably, widely different correlation patterns were observed between study groups. Findings from this pilot study provide some evidence that the homeostasis of autoimmune relationships, which are possibly a physiological part of our immune system, may be altered in FM and ME/CFS. The correlation of disease-induced perturbations in individual AAb profiles with some clinical symptoms may arise from the immune system’s ability to reflect qualitative and quantitative changes in antigenic composition of the body. MDPI 2023-01-18 /pmc/articles/PMC9952981/ /pubmed/36830795 http://dx.doi.org/10.3390/biomedicines11020257 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Ryabkova, Varvara A.
Gavrilova, Natalia Y.
Poletaeva, Alina A.
Pukhalenko, Alexander I.
Koshkina, Irina A.
Churilov, Leonid P.
Shoenfeld, Yehuda
Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
title Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
title_full Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
title_fullStr Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
title_full_unstemmed Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
title_short Autoantibody Correlation Signatures in Fibromyalgia and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Association with Symptom Severity
title_sort autoantibody correlation signatures in fibromyalgia and myalgic encephalomyelitis/chronic fatigue syndrome: association with symptom severity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9952981/
https://www.ncbi.nlm.nih.gov/pubmed/36830795
http://dx.doi.org/10.3390/biomedicines11020257
work_keys_str_mv AT ryabkovavarvaraa autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity
AT gavrilovanataliay autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity
AT poletaevaalinaa autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity
AT pukhalenkoalexanderi autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity
AT koshkinairinaa autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity
AT churilovleonidp autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity
AT shoenfeldyehuda autoantibodycorrelationsignaturesinfibromyalgiaandmyalgicencephalomyelitischronicfatiguesyndromeassociationwithsymptomseverity